Orthopedic Biomaterials Market Insights :
Orthopedic Biomaterials Market is projected to be worth USD 34.66 Billion by 2030, registering a CAGR of 10% during the forecast period (2022-2030), The market was valued at USD 14.70 Billion in 2021. The ceramics & bioactive glass sector led the market in 2020, owing to the rising use of ceramics in the restoration of hard tissues in different procedures. Orthopedic implants are the leading category in 2021, and this dominance is expected to continue throughout the projection period. North America headed the growth of the market in 2021 and is expected to grow at a healthy CAGR during the forecast period.
Orthopedic Biomaterials Market Dynamics:
Orthopedic biomaterials are implanted in the human body as components of devices meant to conduct certain biological activities, such as replacing or fixing diverse tissues such as bone, cartilage, tendons, and ligaments, and even directing bone healing when required.
Driver:
The increasing geriatric population worldwide is a primary driver for the orthopedic biomaterials market. Further increasing advanced treatments for musculoskeletal ailments, rising awareness regarding surgeries among individuals are fueling the growth of the orthopedic biomaterials market.
Restraint:
The lack of reimbursement policy and the increasing middle-class population are expected to hamper the growth of the orthopedic biomaterials market.
Opportunity:
The growing number of surgeries such as arthroplasty, viscosupplementation, and joint reconstruction have created lucrative opportunities for the market. Further, increasing use of nanoparticles in orthopedic bio implants is expected boost the growth prospects for the orthopedic biomaterials market.
COVID-19 Analysis of Orthopedic Biomaterials Market:
The orthopedic biomaterials market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the orthopedic biomaterials market is moderate. Post covid-19 there was a positive impact on the Orthopedic Biomaterials market as consumers were more focused on health, which increased the demand for the orthopedic biomaterials market.
Orthopedic Biomaterials Report Coverage:
Report Attributes | Report Details |
Study Timeline | 2016-2030 |
Market Size in 2030 (USD Billion) | 34.66 |
CAGR (2022-2030) | 10% |
By Material Type | · Ceramics & Bioactive Glasses, Polymers, Calcium Phosphate Cement, Metal, Composites |
By Application | Orthopedic Implants, Joint Replacement/Reconstruction, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation |
By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
Key Players | DSM Biomedical, Evonik Industries AG, Stryker Corp., DePuy Synthes Inc., Zimmer Biomet, Invibio Ltd., Globus Medical, Exactech, Inc., Matexcel, AdvanSource Biomaterials Corp., CAM Bioceramics B.V., and Heraeus Holding. |
Orthopedic Biomaterials Market Segment Analysis:
By Type
The type segment of the orthopedic biomaterials market is divided into polymers, calcium phosphate cement, metals, ceramics, bioactive glass, and composites based on material type. Owing to the rising use of ceramics in the restoration of hard tissues in different procedures, the ceramics & bioactive glass sector led the market in 2020. The polymer sub-segment of the type segment is supposed to grow at the fastest CAGR during the forecast period. Due to the pervasive usage of polymers as load-bearing surfaces and bone cement for total joint arthroplasties. Furthermore, the accessibility of sophisticated polymers and biopolymers for diverse applications such as Orthobiologic and bio-resorbable tissue fixation has increased the global demand for polymers in the orthopedic biomaterials market.
By Application
The application segment of the orthopedic biomaterials market is divided into joint replacement/reconstruction, viscosupplementation, ortho biologics, Orthopedic implants, and bio-resorbable tissue fixation based on application. Orthopedic implants are the leading category in 2021, and this dominance is expected to continue throughout the projection period. Rising rates of disc degeneration and bone fractures, combined with an increase in trauma occurrences, are likely to drive product demand in the orthopedic biomaterials market.
The orthobiologics segment is projected to grow at the fastest rate of 10.3% in the forecast period the factor contributing to the growth is an increase in reconstruction procedures and bone repair globally as a consequence of obesity and trauma cases. According to WHO figures, around 1.3 million people die each year due to road traffic accidents globally, with low-to-middle-income countries accounting for 93% of all road deaths.
By Region
The regional segment includes Asia Pacific, Europe, North America, the Middle East, and Africa, Latin America. North America headed the growth of the market in 2021 and is expected to grow at a healthy CAGR during the forecast period. The increase can be attributed to an increase in the sum of patients demanding knee substitution or replacements, reconstruction, and other Orthopaedic treatments involving joints. The speedy adoption of sophisticated solutions for implant load-bearing and void filling in bones is projected to boost the regional orthopedic biomaterials market further during the forecast period.
Over the projected period, Asia-Pacific is predicted to grow swiftly in the regional market, with a CAGR of 11.5%. The augmented incidence of bone degenerative diseases and bone disorders in low to middle-income nations is one of the key reasons driving the regional market. Additionally, growing healthcare expenses with enhanced healthcare infrastructure are likely to be a high-impact driving force for the market in this area. Hence, the above-mentioned factors are expected to drive the growth of the orthopedic biomaterials market.
Orthopedic Biomaterials Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and product launches have accelerated the growth of the Sample Preparation market. Key players in the market include-
- DSM Biomedical
- Evonik Industries AG
- Stryker Corp.
- DePuy Synthes Inc.
- Zimmer Biomet
- Invibio Ltd.
- Globus Medical
- Exactech, Inc.
- Matexcel
- AdvanSource Biomaterials Corp.
- CAM Bioceramics B.V.
- Heraeus Holding
Recent Development
- In 2019, the first spinal implant Xiphos-ZF spinal device is first developed from Zfuze biomaterial and received US FDA clearance.
- In 2019, the Zimmer Biomet company introduced the Persona Revision knee system and received FDA clearance. This innovation uses trabecular Metal technology.
FAQ
What is the size of Orthopedic Biomaterials Market?
The size of this market is USD 34.66 billion by 2030.
What are the major key players operating in this industry?
DSM Biomedical, Evonik Industries AG, Stryker Corp., DePuy Synthes Inc., Zimmer Biomet are the major key players operating in the market.
Which region predicted to grow swiftly in the regional market CAGR growth?
Asia-Pacific is predicted to grow swiftly in the regional market, with a CAGR growth.
What is the main market-driving factor?
The increasing geriatric population worldwide is a primary driver for the orthopedic biomaterials market. Further increasing advanced treatments for musculoskeletal ailments.
Which is the main application segment in this market?
The orthobiologics implants segment is the main application segment in this market.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Orthopedic Biomaterials
- Global Orthopedic Biomaterials Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Orthopedic Biomaterials Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Orthopedic Biomaterials demand
- Post-Covid Impact on Orthopedic Biomaterials Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Orthopedic Biomaterials Market Segmentation, Revenue (USD Billion), (2022-2030)
- By Type
- Ceramics & Bioactive Glasses
- Polymers
- Calcium Phosphate Cement
- Metal
- Composites
- By Application
- Orthopedic Implants
- Joint Replacement/Reconstruction
- Orthobiologics
- Viscosupplementation
- Bio-resorbable Tissue Fixation
- By Type
- Global Orthopedic Biomaterials Market Overview, By Region
- North America Orthopedic Biomaterials Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Type
- By Application
- Canada
- Mexico
- US
- Europe Orthopedic Biomaterials Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Orthopedic Biomaterials Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Orthopedic Biomaterials Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Orthopedic Biomaterials Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Orthopedic Biomaterials Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Orthopedic Biomaterials Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- DSM Biomedical
- Business Overview
- Business Financials (USD billion)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Evonik Industries AG
- Stryker Corp.
- DePuy Synthes Inc.
- Zimmer Biomet
- Invibio Ltd.
- Globus Medical
- Exactech, Inc.
- Matexcel
- AdvanSource Biomaterials Corp.
- CAM Bioceramics B.V.
- Heraeus Holding
- DSM Biomedical
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.